No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). METHODS: The National Health Insurance Database, part of the Taiwan National Health Insurance Program, was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Chih-Wei, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tsai, Chih-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2016
Materias:
Original Articles: Liver Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051540/
https://www.ncbi.nlm.nih.gov/pubmed/27455080
http://dx.doi.org/10.1097/MEG.0000000000000703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051540/
https://www.ncbi.nlm.nih.gov/pubmed/27455080
http://dx.doi.org/10.1097/MEG.0000000000000703

Ejemplares similares